Co-opted immune homeostatic restraint in cancer: Mechanisms of immunosuppression and implications for immunotherapy resistance
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-11 · 1881 (6) · 189744
DOI: 10.1016/j.bbcan.2026.189744 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026-11. Verfasst von Caini Lan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Institute of Radiation Onc…. Die Arbeit nennt 113 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumors can exploit physiological mechanisms of immune restraint and tissue repair to sustain immunosuppression and limit responses to immunotherapy. This review connects physiological immune regulation with tumor immune escape across checkpoint signaling, metabolism, suppressive immune-cell populations and tissue remodeling. We distinguish activation-coupled negative feedback, persistent deployment of homeostatic or repair programs, and additional tumor-associated suppressive programs, including self-reinforcing circuits. These forms of regulation can coexist and involve shared molecules, but differ in their initiating signals and dependence on continued stimulation or cellular interactions. We examine the evidence linking physiological functions to their altered deployment in cancer and distinguish pre-existing suppression, changes induced during treatment and mechanisms of acquired resistance. We then assess therapeutic strategies according to their experimental and clinical support, including unsuccessful approaches, and discuss how spatial and longitudinal measurements can inform biomarker development and trial design. By linking physiological functions to the processes sustaining suppression, this framework provides a mechanistic basis for classifying immunosuppressive programs. It may guide the selection and timing of therapeutic combinations to achieve more durable antitumor responses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lan, C., Yang, X., Wang, F., Wan, C., & Yang, K. (2026). Co-opted immune homeostatic restraint in cancer: Mechanisms of immunosuppression and implications for immunotherapy resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1881(6), 189744. https://doi.org/10.1016/j.bbcan.2026.189744
Vancouver
Lan C, Yang X, Wang F, Wan C, Yang K. Co-opted immune homeostatic restraint in cancer: Mechanisms of immunosuppression and implications for immunotherapy resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026;1881(6):189744. doi:10.1016/j.bbcan.2026.189744
BibTeX
@article{Lan2026,
author = {Lan, Caini and Yang, Xiao and Wang, Fei and Wan, Chao and Yang, Kunyu},
title = {Co-opted immune homeostatic restraint in cancer: Mechanisms of immunosuppression and implications for immunotherapy resistance},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
volume = {1881},
number = {6},
pages = {189744},
doi = {10.1016/j.bbcan.2026.189744}
}
EUVIMED